Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice

Oncogene

Volumn 33, Issue 5, 2014, Pages 632-642

  Watanabe, K ^a   Fallahi, M ^a   Dai, X ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cancer stem cells; mammary gland; MMTV Wnt1; Pygo2; pygopus 2; tumor heterogeneity

Indexed keywords

ANIMALS; ANTHELMINTICS; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN; FEMALE; GENETIC VARIATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; NEOPLASTIC STEM CELLS; PYRVINIUM COMPOUNDS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; WNT SIGNALING PATHWAY; WNT1 PROTEIN;

EID: 84895069390     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.620     Document Type: Article

References (54)

1. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011; 17: 313-319.
2. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755-768.
3. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737.
4. Gu B, Watanabe K, Dai X. Epithelial stem cells: an epigenetic and Wnt-centric perspective. J Cell Biochem 2010; 110: 1279-1287.
5. Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009; 23: 2563-2577.
6. Raaphorst FM. Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. Trends Immunol 2003; 24: 522-524.
7. Jagani Z, Dorsch M, Warmuth M. Hedgehog pathway activation in chronic myeloid leukemia. Cell cycle 2010; 9: 3449-3456.
8. Khalil S, Tan GA, Giri DD, Zhou XK, Howe LR. Activation status of Wnt/ss-catenin signaling in normal and neoplastic breast tissues: relationship to HER2/neu expression in human and mouse. PloS ONE 2012; 7: e33421.
9. Tepera SB, McCrea PD, Rosen JM. A beta-catenin survival signal is required for normal lobular development in the mammary gland. J Cell Sci 2003; 116(Pt 6): 1137-1149.
10. Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S et al. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 2002; 109: 47-60.
11. Thompson B, Townsley F, Rosin-Arbesfeld R, Musisi H, Bienz M. A new nuclear component of the Wnt signalling pathway. Nat Cell Biol 2002; 4: 367-373.
12. Belenkaya TY, Han C, Standley HJ, Lin X, Houston DW, Heasman J et al. pygopus Encodes a nuclear protein essential for wingless/Wnt signaling. Development 2002; 129: 4089-4101.
13. Parker DS, Jemison J, Cadigan KM. Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila. Development (Cambridge, England) 2002; 129: 2565-2576.
14. Fiedler M, Sanchez-Barrena MJ, Nekrasov M, Mieszczanek J, Rybin V, Mu ller J et al. Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex. Mol Cell 2008; 30: 507-518.
15. Gu B, Sun P, Yuan Y, Moraes RC, Li A, Teng A et al. Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation. J Cell Biol 2009; 185: 811-826.
16. Chen J, Luo Q, Yuan Y, Huang X, Cai W, Li C et al. Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion. Mol Cell Biol 2010; 30: 5621-5635.
17. Andrews PG, He Z, Popadiuk C, Kao KR. The transcriptional activity of Pygopus is enhanced by its interaction with cAMP-response-element-binding protein (CREB)- binding protein. Biochem J 2009; 422: 493-501.
18. Gu B, Watanabe K, Dai X. Pygo2 regulates histone gene expression and H3 K56 acetylation in human mammary epithelial cells. Cell cycle 2011; 11: 79-87.
19. Andrews PG, Lake BB, Popadiuk C, Kao KR. Requirement of Pygopus 2 in breast cancer. Int J Oncol 2007; 30: 357-363.
20. Li Y, Hively WP, Varmus HE. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 2000; 19: 1002-1009.
21. Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008; 68: 7711-7717.
22. Munn RJ, Webster M, Muller WJ, Cardiff RD. Histopathology of transgenic mouse mammary tumors (a short atlas). Sem Cancer Biol 1995; 6: 153-158.
23. Lindeman GJ, Visvader JE. Insights into the cell of origin in breast cancer and breast cancer stem cells. Asia-Pac J Clin Oncol 2010; 6: 89-97.
24. Generation of a functional mammary gland from a single stem cell
25. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Nat Acad Sci Usa 2003; 100: 15853-15858.
26. Liu BY, McDermott SP, Khwaja SS, Alexander CM. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci USA 2004; 101: 4158-4163.
27. Baker R, Kent CV, Silbermann RA, Hassell JA, Young LJ, Howe LR. Pea3 transcription factors and wnt1-induced mouse mammary neoplasia. PloS ONE 2010; 5: e8854.
28. Teissedre B, Pinderhughes A, Incassati A, Hatsell SJ, Hiremath M, Cowin P. MMTVWnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors. PloS ONE 2009; 4: e4537.
29. Zhao H, Langerod A, Ji Y, Nowels KW, Nesland JM, Tibshirani R et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 2004; 15: 2523-2536.
30. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011; 479: 189-193.
31. Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer cell 2006; 10: 437-449.
32. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21: 70-71.
33. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988; 55: 619-625.
34. Smith GH, Mehrel T, Roop DR. Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium. Cell Growth Differ 1990; 1: 161-170.
35. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 2007; 9: 201-209.
36. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 2002; 22: 1184-1193.
37. Kim S, Goel S, Alexander CM. Differentiation generates paracrine cell pairs that maintain basaloid mouse mammary tumors: proof of concept. PloS ONE 2011; 6: e19310.
38. Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, Cselenyi CS et al. Smallmolecule inhibition of Wnt signaling through activation of casein kinase 1alpha. Nat Chem Biol 2011; 6: 829-836.
39. Gjorevski N, Nelson CM. Integrated morphodynamic signalling of the mammary gland. Nature reviews 2011; 12: 581-593.
40. Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha. Cancer Res 1999; 59: 1869-1876.
41. Song N, Schwab KR, Patterson LT, Yamaguchi T, Lin X, Potter SS et al. pygopus 2 has a crucial, Wnt pathway-independent function in lens induction. Development 2007; 134: 1873-1885.
42. Schwab KR, Patterson LT, Hartman HA, Song N, Lang RA, Lin X et al. Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development. BMC Biol 2007; 5: 15.
43. Visvader JE. Cells of origin in cancer. Nature 2011; 469: 314-322.
44. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007; 8: R76.
45. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011; 146: 633-644.
46. Li B, Rheaume C, Teng A, Bilanchone V, Munguia JE, Hu M et al. Developmental phenotypes and reduced Wnt signaling in mice deficient for pygopus 2. Genesis 2007; 45: 318-325.
47. Sun P, Yuan Y, Li A, Li B, Dai X. Cytokeratin expression during mouse embryonic and early postnatal mammary gland development. Histochem Cell Biol 2010; 133: 213-221.
48. Guo W, Lasky JL, Chang CJ, Mosessian S, Lewis X, Xiao Y et al. Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 2008; 453: 529-533.
49. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
50. LaMarca HL, Visbal AP, Creighton CJ, Liu H, Zhang Y, Behbod F et al. CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland. Stem cells (Dayton, Ohio) 2010; 28: 535-544.
51. Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009; 347: 70-78.
52. Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B et al. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 2009; 138: 1083-1095.
53. Karantza-Wadsworth V, White E. A mouse mammary epithelial cell model to identify molecular mechanisms regulating breast cancer progression. Methods Enzymol 2008; 446: 61-76.
54. Eustice DC, Feldman PA, Colberg-Poley AM, Buckery RM, Neubauer RH. A sensitive method for the detection of beta-galactosidase in transfected mammalian cells. Biotechniques 1991; 11: 739-740, 742-743.